Compound kushen injection (CKI) is approved for use in China to treat various cancer tumors, usually as an adjunct to western chemotherapy—but how it works has not been known

Anticancer compound becomes more soluble and selective after glucose is attached

With the potential for a treatment, people with unhappy mast cells may feel better

Indicator of chromosomal instability could be used to predict patient response to cancer treatment

Working with mouse models of colon and breast cancer, researchers demonstrated that when combined with chemotherapy, the nanoparticle reduced tumor growth substantially more than chemotherapy alone

This work resulted in the award of a patent from the U.S. Patent and Trademark Office protecting the use of the compound against various forms of cancer

A  new tumor-modeling platform called a tumor-microenvironment-on-chip can be used to visualize and quantify how different types of cancer cells react differently to the chemotherapy drug doxorubicin

By creating a cell model of medulloblastoma from human cells rather than working with mouse cells, the researchers say they can be more confident that patients’ response to the drugs identified in the screenings may be more comparable to humans

SLU students joined faculty mentors for early research in a cell model

Yeast, human cells, and bioinformatics help develop one-two punch approach to personalized cancer therapy